NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Sesen Bio Inc (F: PCBK)

 
PCBK Technical Analysis
4
As on 7th Mar 2023 PCBK SHARE Price closed @ 0.51 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.70 & Strong Sell for SHORT-TERM with Stoploss of 0.84 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

PCBKSHARE Price

Open 0.51 Change Price %
High 0.51 1 Day -0.03 -5.56
Low 0.51 1 Week -0.02 -3.77
Close 0.51 1 Month -0.05 -8.93
Volume N/A 1 Year -0.38 -42.70
52 Week High 1.18 | 52 Week Low 0.34
 
F Germany Most Active Stocks
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
ENB 47.60 -0.92%
TEF 3.84 -0.52%
TEF 3.84 -0.52%
WHL 5150.00 -0.44%
WDI 0.05 -37.50%
 
F Germany Top Gainers Stocks
JYR 1000000.00 10000000000.00%
JYR 1000000.00 10000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
0AI 11.30 14025.00%
0AI 11.30 14025.00%
SUE1 12.60 12500.00%
1S9 0.20 1900.00%
 
F Germany Top Losers Stocks
TINC 0.01 -99.92%
TINC 0.01 -99.92%
TINC 0.01 -99.92%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
LDB 1.71 -92.57%
 
 
PCBK
Daily Charts
PCBK
Intraday Charts
Whats New @
Bazaartrend
PCBK
Free Analysis
 
PCBK Important Levels Intraday
RESISTANCE0.51
RESISTANCE0.51
RESISTANCE0.51
RESISTANCE0.51
RESISTANCE0.51
RESISTANCE0.51
RESISTANCE0.51
RESISTANCE0.51
 
PCBK Forecast May 2025
4th UP Forecast1.09
3rd UP Forecast0.9
2nd UP Forecast0.79
1st UP Forecast0.67
1st DOWN Forecast0.35
2nd DOWN Forecast0.23
3rd DOWN Forecast0.12
4th DOWN Forecast-0.07
 
PCBK Weekly Forecast
4th UP Forecast0.78
3rd UP Forecast0.69
2nd UP Forecast0.64
1st UP Forecast0.59
1st DOWN Forecast0.43
2nd DOWN Forecast0.38
3rd DOWN Forecast0.33
4th DOWN Forecast0.24
 
PCBK Forecast2025
4th UP Forecast2.3
3rd UP Forecast1.73
2nd UP Forecast1.37
1st UP Forecast1.02
1st DOWN Forecast0
2nd DOWN Forecast-0.35
3rd DOWN Forecast-0.71
4th DOWN Forecast-1.28
 
 
PCBK Other Details
Segment EQ
Market Capital 183454032.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
PCBK Address
PCBK
 
PCBK Latest News
 
Your Comments and Response on Sesen Bio Inc
 
PCBK Business Profile
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. The company's lead product candidates include Vicinium, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC); and VB6-845d, a product candidate for use in the treatment of various types of an anti-epithelial cell adhesion molecule (EpCAM)-positive solid tumors. It also develops Vicinium in combination with Durvalumab, which is in Phase I clinical trials for use in the treatment of BCG-unresponsive NMIBC; and Vicinium in combination with AstraZeneca's checkpoint inhibitor for the treatment of squamous cell carcinoma of the head and neck. Sesen Bio, Inc. has an agreement with Leiden University Medical Center to co-develop an imaging agent. The company was formerly known as Eleven Biotherapeutics, Inc. and changed its name to Sesen Bio, Inc. in May 2018. Sesen Bio, Inc. was incorporated in 2008 and is headquartered in Cambridge, Massachusetts. Address: 245 First Street, Cambridge, MA, United States, 02142
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service